Jason P. Rhodes's most recent trade in Dyne Therapeutics Inc was a trade of 253,039 Common Stock done at an average price of $22.8 . Disclosure was reported to the exchange on July 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.79 per share. | 06 Jul 2026 | 253,039 | 4,223,448 | - | 22.8 | 5,766,759 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.79 per share. | 06 Jul 2026 | 127,182 | 1,217,537 | - | 22.8 | 2,898,478 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 06 Jul 2026 | 124,379 | 4,099,069 | - | 23.2 | 2,881,861 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.79 per share. | 06 Jul 2026 | 100,019 | 875,912 | - | 22.8 | 2,279,433 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 06 Jul 2026 | 62,543 | 1,154,994 | - | 23.2 | 1,449,121 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 06 Jul 2026 | 49,193 | 826,719 | - | 23.2 | 1,139,802 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.62 per share. | 06 Jul 2026 | 29,587 | 4,069,482 | - | 23.6 | 698,845 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.62 per share. | 06 Jul 2026 | 14,844 | 1,140,150 | - | 23.6 | 350,615 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.62 per share. | 06 Jul 2026 | 11,665 | 815,054 | - | 23.6 | 275,527 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.61 per share. | 06 Jul 2026 | 5,000 | 2,962 | - | 23.6 | 118,050 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 26 Jun 2026 | 162,954 | 4,579,456 | - | 21.3 | 3,467,661 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.14 per share. | 26 Jun 2026 | 102,969 | 4,476,487 | - | 21.1 | 2,176,765 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 26 Jun 2026 | 81,903 | 1,396,475 | - | 21.3 | 1,742,896 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 26 Jun 2026 | 64,411 | 1,016,633 | - | 21.3 | 1,370,666 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.14 per share. | 26 Jun 2026 | 51,756 | 1,344,719 | - | 21.1 | 1,094,122 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.14 per share. | 26 Jun 2026 | 40,702 | 975,931 | - | 21.1 | 860,440 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.13 per share. | 23 Jun 2026 | 77,855 | 4,805,639 | - | 21.1 | 1,645,076 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.02 per share. | 23 Jun 2026 | 50,530 | 4,755,109 | - | 21.0 | 1,062,141 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.13 per share. | 23 Jun 2026 | 39,131 | 1,510,157 | - | 21.1 | 826,838 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.13 per share. | 23 Jun 2026 | 30,774 | 1,106,036 | - | 21.1 | 650,255 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.02 per share. | 23 Jun 2026 | 25,397 | 1,484,760 | - | 21.0 | 533,845 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.02 per share. | 23 Jun 2026 | 19,973 | 1,086,063 | - | 21.0 | 419,832 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.10 per share. | 23 Jun 2026 | 12,699 | 4,742,410 | - | 21.1 | 267,949 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.10 per share. | 23 Jun 2026 | 6,382 | 1,478,378 | - | 21.1 | 134,660 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 21.10 per share. | 23 Jun 2026 | 5,019 | 1,081,044 | - | 21.1 | 105,901 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 04 May 2026 | 43,621 | 4,883,494 | - | 18.2 | 793,030 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 04 May 2026 | 21,926 | 1,549,288 | - | 18.2 | 398,615 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 04 May 2026 | 17,244 | 1,136,810 | - | 18.2 | 313,496 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 04 May 2026 | 6,241 | 4,933,196 | - | 18 | 112,338 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 04 May 2026 | 6,081 | 4,927,115 | - | 18.0 | 109,640 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 04 May 2026 | 3,136 | 1,574,270 | - | 18 | 56,448 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 04 May 2026 | 3,056 | 1,571,214 | - | 18.0 | 55,100 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 04 May 2026 | 2,466 | 1,156,457 | - | 18 | 44,388 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 04 May 2026 | 2,403 | 1,154,054 | - | 18.0 | 43,326 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 04 May 2026 | 428 | 7,962 | - | 18.2 | 7,781 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 04 May 2026 | 61 | 8,450 | - | 18 | 1,098 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 04 May 2026 | 60 | 8,390 | - | 18.0 | 1,082 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.38 per share. | 28 Apr 2026 | 119,115 | 4,939,489 | - | 18.4 | 2,189,334 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.38 per share. | 28 Apr 2026 | 59,870 | 1,577,432 | - | 18.4 | 1,100,411 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.38 per share. | 28 Apr 2026 | 47,082 | 1,158,944 | - | 18.4 | 865,367 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.38 per share. | 28 Apr 2026 | 1,170 | 8,512 | - | 18.4 | 21,505 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 28 Apr 2026 | 52 | 4,939,437 | - | 19 | 988 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 28 Apr 2026 | 26 | 1,577,406 | - | 19 | 494 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 28 Apr 2026 | 21 | 1,158,923 | - | 19 | 399 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 28 Apr 2026 | 1 | 8,511 | - | 19 | 19 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 23 Apr 2026 | 90,943 | 5,058,604 | - | 18.1 | 1,650,615 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.48 per share. | 23 Apr 2026 | 72,310 | 5,149,547 | - | 18.5 | 1,336,289 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 23 Apr 2026 | 45,709 | 1,637,302 | - | 18.1 | 829,618 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 23 Apr 2026 | 38,322 | 5,221,857 | - | 19.2 | 735,399 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.48 per share. | 23 Apr 2026 | 36,345 | 1,683,011 | - | 18.5 | 671,656 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 23 Apr 2026 | 35,947 | 1,206,026 | - | 18.1 | 652,438 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.48 per share. | 23 Apr 2026 | 28,583 | 1,241,973 | - | 18.5 | 528,214 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 23 Apr 2026 | 19,261 | 1,719,356 | - | 19.2 | 369,619 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 23 Apr 2026 | 15,148 | 1,270,556 | - | 19.2 | 290,690 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 23 Apr 2026 | 894 | 9,682 | - | 18.1 | 16,226 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 18.48 per share. | 23 Apr 2026 | 710 | 10,576 | - | 18.5 | 13,121 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 23 Apr 2026 | 377 | 11,286 | - | 19.2 | 7,235 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.68 per share. | 20 Apr 2026 | 150,942 | 5,260,179 | - | 19.7 | 2,970,539 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 20 Apr 2026 | 142,604 | 5,554,904 | - | 20.1 | 2,860,636 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 20 Apr 2026 | 142,253 | 5,412,651 | - | 19.5 | 2,775,356 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.68 per share. | 20 Apr 2026 | 75,866 | 1,738,617 | - | 19.7 | 1,493,043 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 20 Apr 2026 | 71,676 | 1,886,751 | - | 20.1 | 1,437,821 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 20 Apr 2026 | 71,499 | 1,815,252 | - | 19.5 | 1,394,945 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.68 per share. | 20 Apr 2026 | 59,663 | 1,285,704 | - | 19.7 | 1,174,168 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 20 Apr 2026 | 56,368 | 1,402,200 | - | 20.1 | 1,130,742 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 20 Apr 2026 | 56,228 | 1,345,972 | - | 19.5 | 1,097,008 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 20 Apr 2026 | 1,530 | 5,411,121 | - | 20.1 | 30,677 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.68 per share. | 20 Apr 2026 | 1,485 | 11,663 | - | 19.7 | 29,225 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 20 Apr 2026 | 1,401 | 14,561 | - | 20.1 | 28,104 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 20 Apr 2026 | 1,398 | 13,163 | - | 19.5 | 27,275 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 20 Apr 2026 | 769 | 1,814,483 | - | 20.0 | 15,418 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 20 Apr 2026 | 605 | 1,345,367 | - | 20.0 | 12,130 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 20 Apr 2026 | 15 | 13,148 | - | 20.1 | 301 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | 09 Feb 2026 | 711,193 | 0 | - | - | Common Stock | ||
| Generation Bio Co | Jason P. Rhodes | Director | 09 Feb 2026 | 116,693 | 0 | - | - | Common Stock | ||
| Generation Bio Co | Jason P. Rhodes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 6,000 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 5,200 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 3,000 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 2,500 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 1,920 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 1,500 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | 09 Feb 2026 | 60 | 0 | - | - | Common Stock | ||
| Generation Bio Co | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 27 Jan 2025 | 1,111,111 | 1,958,427 | - | 13.5 | 14,999,999 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 583 | 5,697,508 | - | 33.1 | 19,297 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 123 | 1,458,568 | - | 33.1 | 4,071 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 72 | 847,316 | - | 33.1 | 2,383 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 14 Nov 2024 | 4 | 15,962 | - | 33 | 132 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Mar 2024 | 29,435 | 1,458,691 | - | 30.1 | 884,522 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Mar 2024 | 17,099 | 847,388 | - | 30.1 | 513,825 | Common Stock |
| Dyne Therapeutics Inc | Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 272,923 | 5,878,544 | - | 24.4 | 6,653,863 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 152,244 | 5,700,521 | - | 24.8 | 3,780,219 | Common Stock |
| Dyne Therapeutics Inc | Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 136,312 | 6,216,250 | - | 23.6 | 3,215,600 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 64,783 | 6,151,467 | - | 24.0 | 1,553,496 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 40,455 | 1,514,874 | - | 24.4 | 986,293 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 25,779 | 5,852,765 | - | 24.7 | 636,226 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 23,505 | 880,022 | - | 24.4 | 573,052 | Common Stock |